These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2331906)

  • 41. New developments in aerosol dosimetry.
    Phalen RF; Mendez LB; Oldham MJ
    Inhal Toxicol; 2010 Dec; 22 Suppl 2():6-14. PubMed ID: 20939685
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deposition and clearance in large and small airways in chronic bronchitis.
    Svartengren K; Ericsson CH; Svartengren M; Mossberg B; Philipson K; Camner P
    Exp Lung Res; 1996; 22(5):555-76. PubMed ID: 8886759
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparing lung regions of interest in gamma scintigraphy for assessing inhaled therapeutic aerosol deposition.
    Biddiscombe MF; Meah SN; Underwood SR; Usmani OS
    J Aerosol Med Pulm Drug Deliv; 2011 Jun; 24(3):165-73. PubMed ID: 21453048
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clearance in smaller airways of inhaled 6-microm particles in subjects with immotile-cilia syndrome.
    Svartengren K; Philipson K; Svartengren M; Nerbrink O; Camner P
    Exp Lung Res; 1995; 21(5):667-82. PubMed ID: 8556987
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Deposition, retention, and clearance of inhaled particles.
    Lippmann M; Yeates DB; Albert RE
    Br J Ind Med; 1980 Nov; 37(4):337-62. PubMed ID: 7004477
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of simulated airway diseases and affected flow distributions on aerosol deposition.
    Apiou-Sbirlea G; Katz IM; Martonen TB
    Respir Care; 2010 Jun; 55(6):707-18. PubMed ID: 20507653
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Controlled, Parametric, Individualized, 2-D and 3-D Imaging Measurements of Aerosol Deposition in the Respiratory Tract of Asthmatic Human Subjects for Model Validation.
    Fleming J; Conway J; Majoral C; Katz I; Caillibotte G; Pichelin M; Montesantos S; Bennett M
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):432-51. PubMed ID: 25859710
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Deposition of ultrafine aerosols in rat nasal molds.
    Cheng YS; Hansen GK; Su YF; Yeh HC; Morgan KT
    Toxicol Appl Pharmacol; 1990 Nov; 106(2):222-33. PubMed ID: 2256113
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Deposition of coarse particles in cystic fibrosis: model predictions versus experimental results.
    Brown JS; Bennett WD
    J Aerosol Med; 2004; 17(3):239-48. PubMed ID: 15625816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of intrinsic particle properties on the assessment of convective gas transport by aerosol bolus technique.
    Schulz H; Schulz A; Heyder J
    Exp Lung Res; 1996; 22(4):393-407. PubMed ID: 8872084
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of exhaled particles from the human lungs in airway obstruction.
    Schwarz K; Biller H; Windt H; Koch W; Hohlfeld JM
    J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):52-8. PubMed ID: 24914577
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of functional respiratory imaging to characterize the effect of inhalation profile and particle size on lung deposition of inhaled corticosteroid/long-acting β2-agonists delivered via a pressurized metered-dose inhaler.
    Van Holsbeke C; De Backer J; Vos W; Marshall J
    Ther Adv Respir Dis; 2018; 12():1753466618760948. PubMed ID: 29499614
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Physiological Factors Affecting Lung Deposition.
    Kim CS
    J Aerosol Med Pulm Drug Deliv; 2021 Jun; 34(3):147-154. PubMed ID: 34152197
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of microgravity and hypergravity on deposition of 0.5- to 3-micron-diameter aerosol in the human lung.
    Darquenne C; Paiva M; West JB; Prisk GK
    J Appl Physiol (1985); 1997 Dec; 83(6):2029-36. PubMed ID: 9390977
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deposition of aerosols in pulmonary disease.
    Goldberg IS; Lourenço RV
    Arch Intern Med; 1973 Jan; 131(1):88-91. PubMed ID: 4682066
    [No Abstract]   [Full Text] [Related]  

  • 56. Increased fine particle deposition in women with asymptomatic nonspecific airway hyperresponsiveness.
    Kohlhäufl M; Brand P; Scheuch G; Meyer TS; Schulz H; Häussinger K; Heyder J
    Am J Respir Crit Care Med; 1999 Mar; 159(3):902-6. PubMed ID: 10051270
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Airflow limitation in sarcoidosis--a study of pulmonary function in 107 patients with newly diagnosed disease.
    Harrison BD; Shaylor JM; Stokes TC; Wilkes AR
    Respir Med; 1991 Jan; 85(1):59-64. PubMed ID: 2014359
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors influencing the deposition of inhaled particles.
    Yeh HC; Phalen RF; Raabe OG
    Environ Health Perspect; 1976 Jun; 15():147-56. PubMed ID: 1001293
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ultrafine particle deposition in subjects with asthma.
    Chalupa DC; Morrow PE; Oberdörster G; Utell MJ; Frampton MW
    Environ Health Perspect; 2004 Jun; 112(8):879-82. PubMed ID: 15175176
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Airborne particles, their use in the respiratory system to measure air flow, function, and clearance.
    Nelson N; Altshuler B; Palmes ED; Albert RE; Lippmann M; Schlesinger R
    Am J Ind Med; 1986; 10(1):7-25. PubMed ID: 3526876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.